Endometriosis Drugs Market Report

Global and Region Endometriosis Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：190
  • REPORT CODE：GMM981294
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.

    The report details the trend, potential and market size of Endometriosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Endometriosis Drugsmarket, defines the market attractiveness level of Endometriosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Endometriosis Drugs industry, describes the types of Endometriosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Endometriosis Drugs market and the development prospects and opportunities of Endometriosis Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Endometriosis Drugs market in Chapter 13.

    By Player:

    • Kissei Pharmaceutical

    • Repros Therapeutics

    • Roivant Sciences GmbH

    • ValiRx

    • AstraZeneca

    • Evotec AG

    • Takeda Pharmaceutical Company Limited

    • Debiopharm Group

    • Pfizer

    • ObsEva

    • AbbVie

    • Astellas Pharma

    • Neurocrine Biosciences

    By Type:

    • Hormonal Therapy

    • Add-back Medication

    • Progestogens

    • Chinese Herbs

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Endometriosis Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Endometriosis Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Endometriosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Endometriosis Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Endometriosis Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Endometriosis Drugs Consumption (2017-2022)

    • 7.2 United States Endometriosis Drugs Consumption (2017-2022)

    • 7.3 Europe Endometriosis Drugs Consumption (2017-2022)

    • 7.4 China Endometriosis Drugs Consumption (2017-2022)

    • 7.5 Japan Endometriosis Drugs Consumption (2017-2022)

    • 7.6 India Endometriosis Drugs Consumption (2017-2022)

    • 7.7 South Korea Endometriosis Drugs Consumption (2017-2022)

    8 Region and Country-wise Endometriosis Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Endometriosis Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Endometriosis Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Endometriosis Drugs Consumption Forecast (2022-2028)

    • 8.4 China Endometriosis Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Endometriosis Drugs Consumption Forecast (2022-2028)

    • 8.6 India Endometriosis Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Endometriosis Drugs Consumption Forecast (2022-2028)

    9 Global Endometriosis Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Endometriosis Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Add-back Medication Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Progestogens Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Chinese Herbs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Endometriosis Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)

    10 Global Endometriosis Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Endometriosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Add-back Medication Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Progestogens Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Chinese Herbs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Endometriosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    11 Global Endometriosis Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Endometriosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Endometriosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Endometriosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Endometriosis Drugs Market Competitive Analysis

    • 14.1 Kissei Pharmaceutical

      • 14.1.1 Kissei Pharmaceutical Company Details

      • 14.1.2 Kissei Pharmaceutical Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Kissei Pharmaceutical Endometriosis Drugs Product and Service

    • 14.2 Repros Therapeutics

      • 14.2.1 Repros Therapeutics Company Details

      • 14.2.2 Repros Therapeutics Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Repros Therapeutics Endometriosis Drugs Product and Service

    • 14.3 Roivant Sciences GmbH

      • 14.3.1 Roivant Sciences GmbH Company Details

      • 14.3.2 Roivant Sciences GmbH Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Roivant Sciences GmbH Endometriosis Drugs Product and Service

    • 14.4 ValiRx

      • 14.4.1 ValiRx Company Details

      • 14.4.2 ValiRx Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 ValiRx Endometriosis Drugs Product and Service

    • 14.5 AstraZeneca

      • 14.5.1 AstraZeneca Company Details

      • 14.5.2 AstraZeneca Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AstraZeneca Endometriosis Drugs Product and Service

    • 14.6 Evotec AG

      • 14.6.1 Evotec AG Company Details

      • 14.6.2 Evotec AG Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Evotec AG Endometriosis Drugs Product and Service

    • 14.7 Takeda Pharmaceutical Company Limited

      • 14.7.1 Takeda Pharmaceutical Company Limited Company Details

      • 14.7.2 Takeda Pharmaceutical Company Limited Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Takeda Pharmaceutical Company Limited Endometriosis Drugs Product and Service

    • 14.8 Debiopharm Group

      • 14.8.1 Debiopharm Group Company Details

      • 14.8.2 Debiopharm Group Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Debiopharm Group Endometriosis Drugs Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Endometriosis Drugs Product and Service

    • 14.10 ObsEva

      • 14.10.1 ObsEva Company Details

      • 14.10.2 ObsEva Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 ObsEva Endometriosis Drugs Product and Service

    • 14.11 AbbVie

      • 14.11.1 AbbVie Company Details

      • 14.11.2 AbbVie Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AbbVie Endometriosis Drugs Product and Service

    • 14.12 Astellas Pharma

      • 14.12.1 Astellas Pharma Company Details

      • 14.12.2 Astellas Pharma Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Astellas Pharma Endometriosis Drugs Product and Service

    • 14.13 Neurocrine Biosciences

      • 14.13.1 Neurocrine Biosciences Company Details

      • 14.13.2 Neurocrine Biosciences Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Neurocrine Biosciences Endometriosis Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Endometriosis Drugs

    • Figure Endometriosis Drugs Picture

    • Table Global Endometriosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Endometriosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Endometriosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Endometriosis Drugs Consumption by Country (2017-2022)

    • Figure United States Endometriosis Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Endometriosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Endometriosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Endometriosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Endometriosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Endometriosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Endometriosis Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Add-back Medication Consumption and Growth Rate (2017-2022)

    • Figure Global Progestogens Consumption and Growth Rate (2017-2022)

    • Figure Global Chinese Herbs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Add-back Medication Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Progestogens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chinese Herbs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Endometriosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Endometriosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Kissei Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kissei Pharmaceutical Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kissei Pharmaceutical Endometriosis Drugs Product and Service

    • Table Repros Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Repros Therapeutics Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Repros Therapeutics Endometriosis Drugs Product and Service

    • Table Roivant Sciences GmbH (Foundation Year, Company Profile and etc.)

    • Table Roivant Sciences GmbH Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roivant Sciences GmbH Endometriosis Drugs Product and Service

    • Table ValiRx (Foundation Year, Company Profile and etc.)

    • Table ValiRx Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table ValiRx Endometriosis Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Endometriosis Drugs Product and Service

    • Table Evotec AG (Foundation Year, Company Profile and etc.)

    • Table Evotec AG Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Evotec AG Endometriosis Drugs Product and Service

    • Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Limited Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Limited Endometriosis Drugs Product and Service

    • Table Debiopharm Group (Foundation Year, Company Profile and etc.)

    • Table Debiopharm Group Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Debiopharm Group Endometriosis Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Endometriosis Drugs Product and Service

    • Table ObsEva (Foundation Year, Company Profile and etc.)

    • Table ObsEva Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table ObsEva Endometriosis Drugs Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Endometriosis Drugs Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Endometriosis Drugs Product and Service

    • Table Neurocrine Biosciences (Foundation Year, Company Profile and etc.)

    • Table Neurocrine Biosciences Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurocrine Biosciences Endometriosis Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US